Caladrius Biosciences Inc (NASDAQ:CLBS)

4.05
Delayed Data
As of May 25
 +0.04 / +1.00%
Today’s Change
2.63
Today|||52-Week Range
6.35
+15.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues17.9M22.5M35.3M0.00
 
 
 
 
Cost of Goods Sold13.8M17.8M28.6M0.00
 
 
 
 
Depreciation And Amortization2.2M2.7M2.7M372.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.0M2.0M3.9M-372.0K
 
 
 
 
 
General Expenses59.7M53.6M35.2M27.2M
 
 
 
 
 
Research And Development29.1M23.8M15.0M15.8M
 
 
 
 
 
Total Operating Expenses75.7M74.1M66.6M27.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-57.7M-51.6M-31.3M-27.6M
 
 
 
 
 
Extraordinary Credit3.1M18.3M0.000.00
 
 
 
Extraordinary Charge---62.3M0.000.00
 
 
Interest Expense On Debt755.7K2.1M1.9M377.8K
 
 
 
 
 
Other Expenses-154.0K-536.4K22.0K273.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-55.6M-98.3M-33.2M-27.7M
 
 
 
 
 
Income Taxes-104.2K-17.2M-138.0K-11.5M
 
 
 
 
 
Minority Interest-593.3K-124.5K-653.2K-182.5K
 
 
 
 
 
Discontinued Operations0.000.000.00-12.8M
 
 
Extraordinary Items0.000.000.0051.7M
 
 
Net Income-54.9M-80.9M-32.7M-28.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.3M4.9M6.5M9.0M
 
 
 
 
 
Shares To Calculate EPS Diluted3.3M4.9M6.5M9.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$16.80-$16.70-$4.99$2.56
 
 
 
 
 
EPS Diluted-$16.80-$16.70-$4.99-$3.21